Updated: Jul 16, 2009
Environmental noise is a common and preventable cause of hearing loss in industrialized societies. Hearing loss that is caused by the noise exposure due to recreational or nonoccupational activities is termed socioacusis. Hearing loss due to injurious noise at workplace is referred to as occupational noise-induced hearing loss (ONIHL). The term acoustic trauma means the hearing loss due to single exposure to intense sound.
ONIHL is a more common cause of noise-induced hearing loss (NIHL) and much more serious problem than socioacusis for the following 2 reasons: (1) The threat of loss of employment may convince people to remain in environments with noise levels higher than they would otherwise accept, and (2) in the workplace, high levels of noise may be sustained on a regular basis for many hours each day over many years. Consequently, occupational noise exposure has drawn the most attention and is the best studied.
Sustained exposure to loud noise is associated with adverse consequences other than hearing loss. For instance, sustained exposure to unwanted loud noise is annoying. Homberg has noted that unwanted noise at any level is annoying; at 72 dB, 100% of subjects rated unwanted noise as either "somewhat annoying" or "rather annoying." Even with hearing protection, Melamed reported that 60% of workers rated high levels of unwanted background noise as "highly annoying."1
Dornie and Laakssonen have investigated the impact of the annoying quality of noise exposure. The annoying quality of loud noise may serve as a warning that it is adversely affecting health, ie, injuring the auditory system. Moreover, the annoying quality of noise reduces processing capacity, thereby increasing the cost of performing a given task. Bhatia reported that individuals who are sensitive to noise show decreased efficacy on multiplication tasks in the presence of unwanted background noise.
Melamed et al have also shown that chronic noise exposure increases fatigue symptoms and postwork irritability.1 They found that, after the workday was over, these fatigue symptoms and postwork irritability made relaxing and being able to unwind extremely difficult. Noise protection that attenuated the unwanted background noise by 30-33 dB for 7 days produced significant improvement in irritability and fatigue symptoms. Furthermore, urinary cortisol secretion was shown to increase with unwanted background noise. The increased urinary cortisol levels decreased toward normal after 7 days of noise attenuation.
Simply measuring the physical intensity of the stimulus as a sound pressure level cannot assess the potentially damaging effect of noise. The human ear does not respond equally to all frequencies—high frequencies are much more damaging than low frequencies at the same physical intensity levels. Consequently, most sound level meters are equipped with a filter that is designed to de-emphasize the physical contribution from frequencies to which the human ear is less sensitive. This filter is referred to as the A filter, and measurements taken using the A filter are reported as dBA. This is known as the A level on a sound pressure meter.When animals exposed to impulse noise are examined, anatomic changes that range from distorted stereocilia of the inner and outer hair cells to complete absence of the organ of Corti and rupture of the Reissner membrane are found. Generally, no changes are found in the blood vessels, spiral ligament, or limbus. A few minutes after exposure to impulse noise, edema of the stria vascularis appears and may persist for several days.
A cochlear inflammatory response is also initiated in response to acoustic trauma and involves the recruitment of circulating leukocytes to the inner ear.2
Outer hair cells are more susceptible to noise exposure than inner hair cells. Temporary threshold shifts (TTS; see History) are anatomically correlated with decreased stiffness of the stereocilia of outer hair cells. The stereocilia become disarrayed and floppy. Presumably, in such a state they respond poorly. At a minimum, permanent threshold shifts (PTS; see History) are associated with fusion of adjacent stereocilia and loss of stereocilia. With more severe exposure, injury can proceed from a loss of adjacent supporting cells to complete disruption of the organ of Corti. Histopathologically, the primary site of injury appears to be the rootlets that connect the stereocilia to the top of the hair cell. With loss of stereocilia, hair cells die. Death of the sensory cell can lead to progressive Wallerian degeneration and loss of primary auditory nerve fibers.
NIHL and hair cell loss are known to show only moderate correlation because NIHL may reflect not only the sum of dead hair cells but also impaired, but still living, hair cells. High-frequency hair cells in rat cochlea may die relatively rapidly after injury, indicating a linear relation between them, but the low-frequency hair cells may survive without auditory function.
Two general theories have been advanced to account for the mechanism of injury. NIHL from constant noise exposure may be secondary to accumulated microtrauma and have a similar mechanism to injury produced from impulse noise. On the other hand, TTS may be due to metabolic exhaustion. Consequently, TTS is sometimes referred as auditory fatigue. Metabolic exhaustion sustained for prolonged periods may be so profound as to result in cell death. The concept of auditory fatigue as an explanation for TTS (with an opportunity for recovery if the noxious acoustic stimulus is removed) may account for the well-described clinical fact that intermittent noise is much less likely to produce permanent injury than continuous noise at the same intensity level.
Apoptosis (programmed cell death) was observed in noise-exposed cochlea.43 An Src–protein tyrosine kinase (PTK) signaling cascade may be involved in both the metabolic and mechanically induced initiation of apoptosis in the sensory cells of cochlea. They may also be activated in outer hair cells following noise exposure. This knowledge, obtained from studies on chinchillas, has led to trials with Src-PTK inhibitors such as KXI-004, KXI-005, and KXI-174 by placing them on round window membrane and noting its beneficial effect in the prevention of NIHL. This may eventually lead to the development of more effective drugs for the prevention of NIHL.
A study on the fate of outer hair cells after acoustic or ototoxic insults showed that outer hair cell remains are phagocytosed by supporting cells within the epithelium.3
Evidence is available to support both the theory of metabolic exhaustion and the theory of mechanical trauma. Experimental animal studies have shown decreased endolymphatic oxygen tension directly related to the duration of intensity of noise exposure. Decreases in succinic dehydrogenase and glycogen content have been observed. However, mechanical models are more compatible with the observation that the greatest area of injury in occupational NIHL appears to be to that portion of a cochlea sensitive to frequencies of about 4000 cycles per second (Hz).
Recent work has clearly demonstrated the presence of glucocorticoid signaling pathways in the cochlea and their protective roles against noise-induced hearing loss. Therefore, taking advantage of current molecular and pharmacological tools to dissect the role of GC signaling in hearing loss is important.4
A gene association study for NIHL in 2 independent noise-exposed populations revealed that PCDH15 and MYH14 may be NIHL susceptibility genes, but further replication in independent sample sets is mandatory.5
The equal energy hypothesis assumed that hearing damage is a function of total acoustic energy received. That the hearing organ reacts uniformly to sounds of various intensities and duration, provided that the total sound energy remains constant, is an oversimplification and does not explain noise-induced hearing damage. A study by Pourbakht et al found that, although the total energy of intermittent sound of 125 dB noise was greater than that of continuous 115 dB sound pressure level, the latter was found to cause significantly greater PTS and hair cell loss.6
Much acoustic trauma is caused by impulse noise, which is usually due to blast effect and the rapid expansion of gases. Acoustic trauma is often the consequence of an explosion. Impact noise results from the collision of metals. It is highly reverberant, has both peaks and valleys, and is less likely to reach critical levels. Impact noise is more likely to be seen in the context of occupational noise exposure. It is frequency superimposed on a background of more sustained noise. Boettcher has shown that when impact noise is superimposed on continuous noise, the injurious potential is synergistically enhanced.
Animals with large PTS from an initial noise exposure showed less PTS following second noise exposure at a specific intensity compared with animals with little or no previous NIHL, indicating that these animals are less sensitive to subsequent noise exposures. However, total PTS in these ears is higher. This suggests that the major factor responsible for these results is lower effective intensity of the second noise for the ears with large initial PTS.
Other physiologic conditions that affect the likelihood and progression of NIHL have been identified. Evidence appears in the literature that decreased body temperature, increased oxygen tension, decreased free radical formation, and removal of the thyroid gland can all lessen an individual's sensitivity to NIHL. Hypoxia potentiates the noise-induced damages. Good experimental evidence shows that sustained exposure to moderately high levels of noise can reduce an individual's sensitivity to NIHL at higher levels of noise. This process is referred to as sound conditioning. It is at least superficially analogous to the protective effect a deliberate training regimen has for severe physical activity.
According to the Occupational Health and Safety Administration (OSHA), 5-10 million Americans are at risk for noise-induced hearing loss (NIHL) because they are exposed to sounds louder than 85 dBA on a sustained basis in the workplace. Forty-eight million Americans engage in shooting sports, the most common cause of nonoccupational NIHL (socioacusis). Dobie reports that 1.8% of American males have handicapping NIHL.7
More males than females are reported to have noise-induced hearing loss (NIHL). However, whether this is a consequence of greater sensitivity to NIHL in the workplace or whether it represents a higher level of exposure to nonoccupational noise is unclear.
No clear-cut differences exist between young and older individuals in their susceptibility to noise-induced hearing loss (NIHL).
The physical examination is not important in the evaluation of noise-induced hearing loss (NIHL) except to rule out other causes. The physical examination should include evaluation of the tympanic membranes and external auditory canals. A neurologic examination should be performed to rule out neurologic diseases.
Noise-induced hearing loss (NIHL) is caused by high levels of ambient noise. OSHA has determined that exposure to loudness levels lower than 85 dBA continuously for an 8-hour workday is unlikely to cause harm. However, sensitive individuals may experience hearing loss even at this or slightly lower levels.
Inner Ear, Autoimmune Disease
Inner Ear, Genetic Sensorineural Hearing
Loss
Inner Ear, Ototoxicity
Inner Ear, Presbycusis
Inner Ear, Sudden Hearing Loss
Middle Ear, Otosclerosis
No laboratory studies are appropriate in the evaluation of noise-induced hearing loss (NIHL).
No imaging studies are appropriate for the study of noise-induced hearing loss (NIHL).
No well-recognized and scientifically validated treatments are specifically directed to noise-induced hearing loss (NIHL). The following treatable conditions have been alleged to exacerbate NIHL by some authors, and appropriate management of these considerations might influence the development or progression of NIHL.
If initiated early, medical treatment could have a role in acute acoustic trauma. Animal studies have shown that a combination of hyperbaric oxygenation and corticoid therapies lead to significant improvement in recovery; however, either of these if given alone may not be effective.9
In an interesting German study on patients with acoustic trauma, intratympanic administration of a cell-permeable JNK ligand was used because it had shown to prevent hearing loss after acute acoustic trauma in animal models.
For the first application of AM-111 in humans, a clinical phase I/II trial in patients was organized in patients with acute acoustic trauma after exposure to firecrackers in Berlin and Munich on New Year's Eve 2005/2006. Functional and morphological analysis of the treated ears revealed that AM-111 had an excellent otoprotective effect, even when administered hours after the noise exposure. Blocking the signal pathway with D-JNKI-1 is therefore a promising way to protect the morphological integrity and physiological function of the inner ear in various conditions involving acute sensorineural hearing loss.
This trial included 11 randomly selected patients on whom intratympanic treatment with AM-111 at a concentration of 0.4 mg/ml or 2 mg/ml within 24 h after noise exposure was performed. Pure-tone audiometry and otoacoustic emissions were assessed before treatment and on days 3 and 30 thereafter. Based on this clinical experience and on a calculation using an empirically derived exponential hearing recovery function, AM-111 seems to have had a therapeutic effect. A total of 13 adverse events were reported in 5 study participants. None of the adverse events were serious or severe.10
Future treatment options
An animal study found that when neural stem cells (cNSCs) were injected into the scala tympani of sound-damaged mice and guinea pigs, and the animals were allowed to recover for up to 6 weeks, some of the cNSCs migrated throughout the cochlea and demonstrated morphological, protein, and genetic characteristics of neural cochlear tissue (eg, spiral ganglion neurons, satellite cells, Schwann cells) and cells of the organ of Corti (pillar cells, supporting cells, and hair cells).11 This suggests that neural stem cell line may derive some information needed from the microenvironment of the cochlea to differentiate into replacement cells in the cochlea. This could help in future treatment development and entirely change the management of hearing loss resulting from damage to these cells.
For excellent patient education resources, visit eMedicine's Ear, Nose, and Throat Center. Also, see eMedicine's patient education article Hearing Loss and Tinnitus.
Melamed S, Rabinowitz S, Green MS. Noise exposure, noise annoyance, use of hearing protection devices and distress among blue-collar workers. Scand J Work Environ Health. Aug 1994;20(4):294-300. [Medline].
Tornabene SV, Sato K, Pham L, Billings P, Keithley EM. Immune cell recruitment following acoustic trauma. Hear Res. Dec 2006;222(1-2):115-24. [Medline].
Abrashkin KA, Izumikawa M, Miyazawa T, et al. The fate of outer hair cells after acoustic or ototoxic insults. Hear Res. Aug 2006;218(1-2):20-9. [Medline].
Jin DX, Lin Z, Lei D, Bao J. The role of glucocorticoids for spiral ganglion neuron survival. Brain Res. Jun 24 2009;1277:3-11. [Medline].
Konings A, Van Laer L, Wiktorek-Smagur A, et al. Candidate gene association study for noise-induced hearing loss in two independent noise-exposed populations. Ann Hum Genet. Mar 2009;73(2):215-24. [Medline].
Pourbakht A, Yamasoba T. Cochlear damage caused by continuous and intermittent noise exposure. Hear Res. Apr 2003;178(1-2):70-8. [Medline].
Dobie RA. The relative contributions of occupational noise and aging in individual cases of hearing loss. Ear Hear. Feb 1992;13(1):19-27. [Medline].
Dobie RA. A method for allocation of hearing handicap. Otolaryngol Head Neck Surg. Nov 1990;103(5 (Pt 1)):733-9. [Medline].
Fakhry N, Rostain JC, Cazals Y. Hyperbaric oxygenation with corticoid in experimental acoustic trauma. Hear Res. Aug 2007;230(1-2):88-92. [Medline].
Suckfuell M, Canis M, Strieth S, Scherer H, Haisch A. Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase I/II study. Acta Otolaryngol. Sep 2007;127(9):938-42. [Medline].
Parker MA, Corliss DA, Gray B, et al. Neural stem cells injected into the sound-damaged cochlea migrate throughout the cochlea and express markers of hair cells, supporting cells, and spiral ganglion cells. Hear Res. Oct 2007;232(1-2):29-43. [Medline].
Job A, Raynal M, Kossowski M, et al. Otoacoustic detection of risk of early hearing loss in ears with normal audiograms: a 3-year follow-up study. Hear Res. May 2009;251(1-2):10-6. [Medline].
Campbell KC, Meech RP, Klemens JJ, et al. Prevention of noise- and drug-induced hearing loss with D-methionine. Hear Res. Apr 2007;226(1-2):92-103. [Medline].
Bielefeld EC, Kopke RD, Jackson RL, Coleman JK, Liu J, Henderson D. Noise protection with N-acetyl-l-cysteine (NAC) using a variety of noise exposures, NAC doses, and routes of administration. Acta Otolaryngol. Sep 2007;127(9):914-9. [Medline].
Hamernik RP, Qiu W, Davis B. The effectiveness of N-acetyl-L-cysteine (L-NAC) in the prevention of severe noise-induced hearing loss. Hear Res. May 2008;239(1-2):99-106. [Medline].
American Medical Association. Guides to the Evaluation of Permanent Impairment. 4th ed. Chicago: American Medical Association; 1993.
Arslan E, Orzan E. Audiological management of noise induced hearing loss. Scand Audiol Suppl. 1998;48:131-45. [Medline].
Boettcher FA, Henderson D, Gratton MA, Danielson RW, Byrne CD. Synergistic interactions of noise and other ototraumatic agents. Ear Hear. Aug 1987;8(4):192-212. [Medline].
Canlon B. Protection against noise trauma by sound conditioning. Ear Nose Throat J. Apr 1997;76(4):248-50, 253-5. [Medline].
Chen GD, Liu Y. Mechanisms of noise-induced hearing loss potentiation by hypoxia. Hear Res. Feb 2005;200(1-2):1-9. [Medline].
Conference report. Consensus conference. Noise and hearing loss. JAMA. Jun 20 1990;263(23):3185-90. [Medline].
DiBiase P, Arriaga MA. Post-traumatic hydrops. Otolaryngol Clin North Am. Dec 1997;30(6):1117-22. [Medline].
Harris KC, Hu B, Hangauer D, Henderson D. Prevention of noise-induced hearing loss with Src-PTK inhibitors. Hear Res. Oct 2005;208(1-2):14-25. [Medline].
Hone SW, Norman G, Keogh I, Kelly V. The use of cortical evoked response audiometry in the assessment of noise-induced hearing loss. Otolaryngol Head Neck Surg. Feb 2003;128(2):257-62. [Medline].
Hou F, Wang S, Zhai S, Hu Y, Yang W, He L. Effects of alpha-tocopherol on noise-induced hearing loss in guinea pigs. Hear Res. May 2003;179(1-2):1-8. [Medline].
Hu BH, Guo W, Wang PY, Henderson D, Jiang SC. Intense noise-induced apoptosis in hair cells of guinea pig cochleae. Acta Otolaryngol. Jan 2000;120(1):19-24. [Medline].
Konopka W, Pawlaczyk-Luszczynska M, Sliwinska-Kowalska M, Grzanka A, Zalewski P. Effects of impulse noise on transiently evoked otoacoustic emission in soldiers. Int J Audiol. Jan 2005;44(1):3-7. [Medline].
Kumar A, Mathur NN, Varghese M, Mohan D, Singh JK, Mahajan P. Effect of tractor driving on hearing loss in farmers in India. Am J Ind Med. Apr 2005;47(4):341-8. [Medline].
Lamm K, Lamm H, Arnold W. Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise-induced hearing loss and tinnitus. A literature survey. Adv Otorhinolaryngol. 1998;54:86-99. [Medline].
Lusk SL. Noise exposures. Effects on hearing and prevention of noise induced hearing loss. AAOHN J. Aug 1997;45(8):397-408; quiz 409-10. [Medline].
Madigan J. Beyond hearing loss. Occup Health Saf. Oct 1998;67(10):84-9. [Medline].
Morata TC. Assessing occupational hearing loss: beyond noise exposures. Scand Audiol Suppl. 1998;48:111-6. [Medline].
Perez R, Freeman S, Sohmer H. Effect of an initial noise induced hearing loss on subsequent noise induced hearing loss. Hear Res. Jun 2004;192(1-2):101-6. [Medline].
Picard M, Banville R, Barbarosie T, Manolache M. Speech audiometry in noise-exposed workers: the SRT-PTA relationship revisited. Audiology. Jan-Feb 1999;38(1):30-43. [Medline].
Prasher D, Sulkowski W. The role of otoacoustic emissions in screening and evaluation of noise damage. Int J Occup Med Environ Health. 1999;12(2):183-92. [Medline].
Sataloff RT, Sataloff J. Audiologic testing: an overview for occupational physicians. Occup Med. Jul-Sep 1997;12(3):433-47. [Medline].
Sohmer H. Pathophysiological mechanisms of hearing loss. J Basic Clin Physiol Pharmacol. 1997;8(3):113-25. [Medline].
Stewart M, Konkle DF, Simpson TH. The effect of recreational gunfire noise on hearing in workers exposed to occupational noise. Ear Nose Throat J. Jan 2001;80(1):32-4, 36, 38-40. [Medline].
Subratty AH, Hooloman NK. Role of circulating inflammatory cytokines in patients during an acute attack of bronchial asthma. Indian J Chest Dis Allied Sci. Jan-Mar 1998;40(1):17-21. [Medline].
Takemura K, Komeda M, Yagi M, et al. Direct inner ear infusion of dexamethasone attenuates noise-induced trauma in guinea pig. Hear Res. Oct 2004;196(1-2):58-68. [Medline].
Teie PU. Noise-induced hearing loss and symphony orchestra musicians: risk factors, effects, and management. Md Med J. Jan 1998;47(1):13-8. [Medline].
Tornabene SV, Sato K, Pham L, Billings P, Keithley EM. Immune cell recruitment following acoustic trauma. Hear Res. Dec 2006;222(1-2):115-24. [Medline].
Hu BH, Guo W, Wang PY, Henderson D, Jiang SC. Intense noise-induced apoptosis in hair cells of guinea pig cochleae. Acta Otolaryngol. Jan 2000;120(1):19-24. [Medline].
hearing loss, noise-induced hearing loss, NIHL, non-occupational hearing loss, socioacusis, environmental noise, noise exposure, occupational hearing loss, occupational noise-induced hearing loss, ONIHL, acoustic trauma, workplace noise
Neeraj N Mathur, MBBS, MS, Professor, Department of Ear, Nose and Throat, Lady Hardinge Medical College and Associated Smt SK and Kalawati, Saran Children's Hospital, University of Delhi, India; Professor and Head, Department of Ear, Nose and Throat, BP Koirala Institute of Health Sciences, Nepal
Neeraj N Mathur, MBBS, MS is a member of the following medical societies: Association of Otolaryngologists of India, Cochlear Implant Group of India, Indian Medical Association, National Academy of Medical Sciences, India, Neuro-Otologic and Equlibriometric Society of India, and Royal Society of Medicine
Disclosure: Nothing to disclose.
Peter S Roland, MD, Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director of Clinical Center for Auditory, Vestibular and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Adjunct Professor of Communicative Disorders, University of Texas School of Human Development
Peter S Roland, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American Laryngological Rhinological and Otological Society, American Neurotology Society, American Otological Society, North American Skull Base Society, and Society of University Otolaryngologists-Head and Neck Surgeons
Disclosure: Alcon labs Honoraria Speaking and teaching; GSK Honoraria Speaking and teaching; Advanced Bionics Honoraria Board membership; Cochlear corp Honoraria Board membership; Med El corp travel grants Consulting
S Valentine Fernandes, MBBS, MCPS, FRCSEd, FRACS, FACS, Conjoint Senior Clinical Lecturer, Department of Otorhinolaryngology, Newcastle University; Senior Consultant Surgeon, Department of Otorhinolaryngology-Head and Neck Surgery, John Hunter, Toronto Private and Kurri Hospitals, Australia
S Valentine Fernandes, MBBS, MCPS, FRCSEd, FRACS, FACS is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American College of Surgeons
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment
Gerard J Gianoli, MD, Clinical Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine; Vice President, The Ear and Balance Institute; Chief Executive Officer, Ponchartrain Surgery Center
Gerard J Gianoli, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Neurotology Society, American Otological Society, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society
Disclosure: Nothing to disclose.
Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.
Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo Consulting; Medvoy Ownership interest Management position
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)